| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.38 | 500 | 3,689 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.39 | 1,000 | 7,391 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.28 | 1,000 | 9,277 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 601,515 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.02 | 37,210 | 335,760 | 582,805 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.28 | 1,000 | 9,277 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.26 | 500 | 4,632 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 15, 2022 | Option Exercise | $11.86 | 5,751 | 68,207 | 570,265 | Nov 17, 2022, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,098 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 594,209 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.00 | 36,693 | 366,947 | 576,016 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,099 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.11 | 500 | 5,055 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,643 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 580,512 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.58 | 36,053 | 417,468 | 562,959 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,641 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 500 | 5,821 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,502 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 567,328 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.34 | 36,566 | 377,944 | 549,262 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,504 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 500 | 5,249 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 15, 2022 | Option Exercise | $12.96 | 5,751 | 74,533 | 536,078 | Aug 17, 2022, 06:32 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 560,154 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.49 | 36,825 | 349,441 | 541,829 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.45 | 1,000 | 9,447 | 0 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.44 | 500 | 4,722 | 0 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.45 | 1,000 | 9,448 | 0 | Aug 05, 2022, 07:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 547,518 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $9.05 | 37,114 | 335,978 | 528,904 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $9.07 | 1,000 | 9,068 | 0 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $9.06 | 500 | 4,531 | 0 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 07, 2022 | Sale | $9.07 | 1,000 | 9,070 | 0 | Jul 08, 2022, 06:36 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $6.35 | 1,000 | 6,346 | 0 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 537,458 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $6.09 | 39,690 | 241,766 | 516,268 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $6.34 | 1,000 | 6,341 | 0 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 02, 2022 | Sale | $6.34 | 500 | 3,172 | 0 | Jun 06, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 16, 2022 | Option Exercise | $5.67 | 5,764 | 32,682 | 506,208 | May 18, 2022, 07:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Sale | $6.48 | 1,000 | 6,481 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 18,500 | 119,118 | 511,972 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 525,302 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 1,000 | 6,439 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Sale | $6.49 | 31,830 | 206,497 | 511,972 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 500 | 3,221 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Sale | $6.47 | 1,000 | 6,474 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 05, 2022 | Sale | $6.43 | 1,000 | 6,435 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 04, 2022 | Sale | $6.47 | 500 | 3,235 | 0 | May 06, 2022, 08:13 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 29, 2022 | Sale | $6.31 | 500 | 3,156 | 0 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 28, 2022 | Sale | $6.05 | 500 | 3,026 | 0 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 29, 2022 | Sale | $6.30 | 1,000 | 6,304 | 0 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 28, 2022 | Sale | $6.07 | 1,000 | 6,069 | 0 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 29, 2022 | Option Exercise | $2.48 | 44,014 | 109,155 | 513,622 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 28, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 488,713 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 29, 2022 | Sale | $6.18 | 38,070 | 235,333 | 494,052 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 28, 2022 | Sale | $6.09 | 37,605 | 229,116 | 469,608 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 29, 2022 | Sale | $6.31 | 1,000 | 6,307 | 0 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 28, 2022 | Sale | $6.07 | 1,000 | 6,070 | 0 | May 02, 2022, 09:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 22, 2022 | Sale | $5.99 | 500 | 2,995 | 0 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 21, 2022 | Sale | $6.19 | 500 | 3,097 | 0 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 22, 2022 | Sale | $6.01 | 1,000 | 6,006 | 0 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 21, 2022 | Sale | $6.18 | 1,000 | 6,184 | 0 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 21, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 438,801 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 22, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 464,156 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 21, 2022 | Sale | $6.31 | 37,155 | 234,629 | 420,146 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 22, 2022 | Sale | $6.04 | 37,953 | 229,175 | 444,703 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 21, 2022 | Sale | $6.18 | 1,000 | 6,185 | 0 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 22, 2022 | Sale | $6.00 | 1,000 | 6,005 | 0 | Apr 25, 2022, 09:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 18, 2022 | Sale | $6.72 | 500 | 3,358 | 0 | Apr 20, 2022, 09:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 18, 2022 | Sale | $6.71 | 1,000 | 6,706 | 0 | Apr 20, 2022, 09:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 18, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 412,127 | Apr 20, 2022, 09:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 18, 2022 | Sale | $6.84 | 35,836 | 245,072 | 394,791 | Apr 20, 2022, 09:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 18, 2022 | Sale | $6.71 | 1,000 | 6,706 | 0 | Apr 20, 2022, 09:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 14, 2022 | Sale | $7.51 | 1,000 | 7,512 | 0 | Apr 18, 2022, 09:46 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 14, 2022 | Sale | $7.50 | 500 | 3,750 | 0 | Apr 18, 2022, 09:46 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 14, 2022 | Sale | $7.51 | 1,000 | 7,505 | 0 | Apr 18, 2022, 09:46 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 14, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 384,134 | Apr 18, 2022, 09:46 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 14, 2022 | Sale | $7.56 | 34,517 | 260,863 | 368,117 | Apr 18, 2022, 09:46 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 08, 2022 | Sale | $6.71 | 1,000 | 6,713 | 0 | Apr 12, 2022, 08:05 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 08, 2022 | Sale | $6.69 | 500 | 3,347 | 0 | Apr 12, 2022, 08:05 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 08, 2022 | Sale | $6.71 | 1,000 | 6,712 | 0 | Apr 12, 2022, 08:05 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 08, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 358,544 | Apr 12, 2022, 08:05 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 08, 2022 | Sale | $6.59 | 36,920 | 243,219 | 340,124 | Apr 12, 2022, 08:05 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 07, 2022 | Sale | $6.52 | 1,000 | 6,522 | 0 | Apr 11, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 07, 2022 | Sale | $6.50 | 500 | 3,248 | 0 | Apr 11, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 07, 2022 | Sale | $6.51 | 1,000 | 6,512 | 0 | Apr 11, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 07, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 332,752 | Apr 11, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 07, 2022 | Sale | $6.54 | 36,718 | 240,238 | 314,534 | Apr 11, 2022, 08:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 06, 2022 | Sale | $6.77 | 35,826 | 242,713 | 288,742 | Apr 08, 2022, 07:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 06, 2022 | Sale | $6.56 | 1,000 | 6,561 | 0 | Apr 08, 2022, 07:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 06, 2022 | Sale | $6.55 | 500 | 3,277 | 0 | Apr 08, 2022, 07:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 06, 2022 | Sale | $6.57 | 1,000 | 6,568 | 0 | Apr 08, 2022, 07:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 06, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 306,068 | Apr 08, 2022, 07:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2022 | Sale | $7.43 | 34,472 | 256,234 | 262,058 | Apr 07, 2022, 09:15 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2022 | Sale | $7.31 | 1,000 | 7,309 | 0 | Apr 07, 2022, 09:15 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2022 | Sale | $7.33 | 500 | 3,666 | 0 | Apr 07, 2022, 09:15 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2022 | Sale | $7.31 | 1,000 | 7,309 | 0 | Apr 07, 2022, 09:15 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2022 | Option Exercise | $2.48 | 44,010 | 109,145 | 278,030 | Apr 07, 2022, 09:15 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 11, 2022 | Sale | $6.95 | 100,000 | 694,580 | 234,020 | Mar 15, 2022, 08:57 PM |
Menu